Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
Adrienne Y L Chan(Aston University), Ian Chi Kei Wong(University of London), Le Gao(University of Hong Kong), Kenneth K. C. Man(University College London Hospitals NHS Foundation Trust), Patrick Ip(University of Hong Kong), Yingfen Hsia(Queen's University Belfast), Emily Simonoff(King's College London), Yogini Jani(University College London Hospitals NHS Foundation Trust), Terry Yat Sang Lum(University of Hong Kong), Katja Taxis(University of Groningen), Wallis C. Y. Lau(University College London Hospitals NHS Foundation Trust), David Coghill(The University of Melbourne), David Taylor(École Polytechnique Fédérale de Lausanne), Li Wei(University College London), Tiantian Ma(Laboratory of Data Discovery for Health)
Cited by 70
Related Papers
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder
|Neuroscience & Biobehavioral Reviews|2021|1.4k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
|Psychopharmacology|2017|969
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality
|Journal of Bone and Mineral Research|2023|506